Ashley A. Woodcock

机构：Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust · ORCID：0000-0002-5428-8578

发表论文 520 篇 · 总被引 24300 次 · h-index 86

代表论文

• Long COVID: pathophysiological factors and abnormalities of coagulation (2023 · Trends in Endocrinology and Metabolism · 被引 254)
• Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial (2020 · The Lancet Respiratory Medicine · 被引 146)
• Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis (2022 · Thorax · 被引 116)
• The environmental impact of inhalers for asthma: A green challenge and a golden opportunity (2021 · British Journal of Clinical Pharmacology · 被引 108)
• Exacerbation Profile and Risk Factors in a Type-2–Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes (2022 · American Journal of Respiratory and Critical Care Medicine · 被引 89)
• The environmental impact of inhaled therapy: making informed treatment choices (2021 · European Respiratory Journal · 被引 83)